281 related articles for article (PubMed ID: 16965327)
1. Hereditary lymphedema type I associated with VEGFR3 mutation: the first de novo case and atypical presentations.
Ghalamkarpour A; Morlot S; Raas-Rothschild A; Utkus A; Mulliken JB; Boon LM; Vikkula M
Clin Genet; 2006 Oct; 70(4):330-5. PubMed ID: 16965327
[TBL] [Abstract][Full Text] [Related]
2. Recessive primary congenital lymphoedema caused by a VEGFR3 mutation.
Ghalamkarpour A; Holnthoner W; Saharinen P; Boon LM; Mulliken JB; Alitalo K; Vikkula M
J Med Genet; 2009 Jun; 46(6):399-404. PubMed ID: 19289394
[TBL] [Abstract][Full Text] [Related]
3. Clinical variability in a Japanese hereditary lymphedema type I family with an FLT4 mutation.
Mizuno S; Yamada Y; Yamada K; Nomura N; Wakamatsu N
Congenit Anom (Kyoto); 2005 Jun; 45(2):59-61. PubMed ID: 15904433
[TBL] [Abstract][Full Text] [Related]
4. Sporadic in utero generalized edema caused by mutations in the lymphangiogenic genes VEGFR3 and FOXC2.
Ghalamkarpour A; Debauche C; Haan E; Van Regemorter N; Sznajer Y; Thomas D; Revencu N; Gillerot Y; Boon LM; Vikkula M
J Pediatr; 2009 Jul; 155(1):90-3. PubMed ID: 19394045
[TBL] [Abstract][Full Text] [Related]
5. Three children with Milroy disease and de novo mutations in VEGFR3.
Carver C; Brice G; Mansour S; Ostergaard P; Mortimer P; Jeffery S;
Clin Genet; 2007 Feb; 71(2):187-9. PubMed ID: 17250670
[No Abstract] [Full Text] [Related]
6. Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema.
Gordon K; Schulte D; Brice G; Simpson MA; Roukens MG; van Impel A; Connell F; Kalidas K; Jeffery S; Mortimer PS; Mansour S; Schulte-Merker S; Ostergaard P
Circ Res; 2013 Mar; 112(6):956-60. PubMed ID: 23410910
[TBL] [Abstract][Full Text] [Related]
7. Hydrops fetalis: an unusual prenatal presentation of hereditary congenital lymphedema.
Daniel-Spiegel E; Ghalamkarpour A; Spiegel R; Weiner E; Vikkula M; Shalev E; Shalev SA
Prenat Diagn; 2005 Nov; 25(11):1015-8. PubMed ID: 16231305
[TBL] [Abstract][Full Text] [Related]
8. A novel VEGFR3 mutation causes Milroy disease.
Butler MG; Dagenais SL; Rockson SG; Glover TW
Am J Med Genet A; 2007 Jun; 143A(11):1212-7. PubMed ID: 17458866
[TBL] [Abstract][Full Text] [Related]
9. Milroy's primary congenital lymphedema in a male infant and review of the literature.
Kitsiou-Tzeli S; Vrettou C; Leze E; Makrythanasis P; Kanavakis E; Willems P
In Vivo; 2010; 24(3):309-14. PubMed ID: 20555004
[TBL] [Abstract][Full Text] [Related]
10. Antenatal presentation of hereditary lymphedema type I.
Boudon E; Levy Y; Abossolo T; Cartault F; Brouillard P; Vikkula M; Kieffer-Traversier M; Ramful D; Alessandri JL
Eur J Med Genet; 2015; 58(6-7):329-31. PubMed ID: 25896638
[TBL] [Abstract][Full Text] [Related]
11. FLT4/VEGFR3 and Milroy disease: novel mutations, a review of published variants and database update.
Gordon K; Spiden SL; Connell FC; Brice G; Cottrell S; Short J; Taylor R; Jeffery S; Mortimer PS; Mansour S; Ostergaard P
Hum Mutat; 2013 Jan; 34(1):23-31. PubMed ID: 23074044
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas.
Connell FC; Ostergaard P; Carver C; Brice G; Williams N; Mansour S; Mortimer PS; Jeffery S;
Hum Genet; 2009 Jan; 124(6):625-31. PubMed ID: 19002718
[TBL] [Abstract][Full Text] [Related]
13. Wide clinical spectrum in a family with hereditary lymphedema type I due to a novel missense mutation in VEGFR3.
Spiegel R; Ghalamkarpour A; Daniel-Spiegel E; Vikkula M; A Shalev S
J Hum Genet; 2006; 51(10):846-850. PubMed ID: 16924388
[TBL] [Abstract][Full Text] [Related]
14. A novel FLT4 mutation identified in a patient with Milroy disease.
DiGiovanni RM; Erickson RP; Ohlson EC; Bernas M; Witte MH
Lymphology; 2014 Mar; 47(1):44-7. PubMed ID: 25109169
[TBL] [Abstract][Full Text] [Related]
15. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase.
Irrthum A; Karkkainen MJ; Devriendt K; Alitalo K; Vikkula M
Am J Hum Genet; 2000 Aug; 67(2):295-301. PubMed ID: 10856194
[TBL] [Abstract][Full Text] [Related]
16. Age of onset in hereditary lymphedema.
Levinson KL; Feingold E; Ferrell RE; Glover TW; Traboulsi EI; Finegold DN
J Pediatr; 2003 Jun; 142(6):704-8. PubMed ID: 12838201
[TBL] [Abstract][Full Text] [Related]
17. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
18. Two novel variations p.(Ser1275Thr) and p.(Ser1275Arg) in FLT4 causing prenatal hereditary lymphedema type 1.
Lajmi Y; Loeuillet L; Petrilli G; Egloff C; Nectoux J; Molac C; Roux N; Pannier E; Achaiaa A; Arkoub ZA; Chuon S; Coussement A; Dupont JM; Malan V; Spaggiari E; Razavi F; Amiel J; Bessières B; Grotto S; Attié-Bitach T
Birth Defects Res; 2023 Mar; 115(5):563-571. PubMed ID: 36538874
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia.
Irrthum A; Devriendt K; Chitayat D; Matthijs G; Glade C; Steijlen PM; Fryns JP; Van Steensel MA; Vikkula M
Am J Hum Genet; 2003 Jun; 72(6):1470-8. PubMed ID: 12740761
[TBL] [Abstract][Full Text] [Related]
20. A Novel Missense Mutation in FLT4 Causes Autosomal Recessive Hereditary Lymphedema.
Melikhan-Revzin S; Kurolap A; Dagan E; Mory A; Gershoni-Baruch R
Lymphat Res Biol; 2015 Jun; 13(2):107-11. PubMed ID: 26091405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
